Target Name: SCARNA8
NCBI ID: G677776
Review Report on SCARNA8 Target / Biomarker Content of Review Report on SCARNA8 Target / Biomarker
SCARNA8
Other Name(s): U92 | Small Cajal body-specific RNA 8 | small Cajal body-specific RNA 8

SCARNA8 Plays A Crucial Role in Brain Function

SCARNA8 (U92) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the scaffold protein family, which plays a crucial role in the structure and function of tissues. U92 is a unique protein that is expressed in the brain and has been shown to be involved in a number of important cellular processes.

One of the key functions of SCARNA8 is its role in the formation of the blood-brain barrier. The blood-brain barrier is a specialized barrier that separates the brain from the surrounding bloodstream, and it is designed to protect the brain from harmful substances and to allow only certain types of cells to enter the brain. The formation of the blood-brain barrier is critical for the survival and function of the brain, and SCARNA8 is involved in this process in several ways.

First, SCARNA8 helps to regulate the formation of new blood vessels in the brain. Blood vessels are essential for the delivery of oxygen and nutrients to the brain, and they are also important for removing waste products. The formation of new blood vessels in the brain is critical for ensuring that the brain has access to the oxygen and nutrients it needs to function properly. SCARNA8 plays a key role in this process by helping to regulate the growth and differentiation of blood vessels.

Second, SCARNA8 helps to maintain the structure and integrity of the blood-brain barrier. The blood-brain barrier is made up of several different proteins that work together to ensure that the barrier is able to function effectively. SCARNA8 is one of these proteins, and it plays a critical role in maintaining the structure and integrity of the barrier. This is important because the blood-brain barrier helps to protect the brain from harmful substances that could otherwise enter the brain and cause damage.

Third, SCARNA8 is involved in the regulation of neurotransmitter release from the brain. Neurotransmitters are important molecules that are used by the brain to communicate with other cells and to regulate various physiological processes. SCARNA8 is involved in the regulation of neurotransmitter release from the brain, which is critical for the proper functioning of the brain.

Finally, SCARNA8 is also involved in the regulation of the formation of new neurons in the brain. Neurons are the fundamental units of the brain, and they are responsible for many of the complex functions that the brain is able to perform. The formation of new neurons in the brain is critical for the development and maintenance of normal brain function, and SCARNA8 is involved in this process.

In conclusion, SCARNA8 is a protein that is expressed in various tissues of the body and plays a crucial role in the formation of the blood-brain barrier, the regulation of neurotransmitter release from the brain, and the regulation of the formation of new neurons in the brain. These functions are critical for the proper functioning of the brain and are therefore of great interest to researchers. Further research is needed to fully understand the role of SCARNA8 in these processes and to determine its potential as a drug target or biomarker.

Protein Name: Small Cajal Body-specific RNA 8

The "SCARNA8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCARNA8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SCARNA9 | SCARNA9L | SCART1 | SCAT1 | SCCPDH | SCD | SCD5 | SCDP1 | SCEL | SCF (SKP1-CUL1-F-box protein) Ubiquitin Ligase Complex | SCF Ubiquitin Ligase Complex | SCFD1 | SCFD2 | SCG2 | SCG3 | SCG5 | SCGB1A1 | SCGB1B2P | SCGB1C1 | SCGB1D1 | SCGB1D2 | SCGB1D4 | SCGB2A1 | SCGB2A2 | SCGB2B2 | SCGB3A1 | SCGB3A2 | SCGN | SCHIP1 | SCHLAP1 | SCIMP | SCIN | SCIRT | SCLT1 | SCLY | SCMH1 | SCML1 | SCML2 | SCML4 | SCN10A | SCN11A | SCN1A | SCN1A-AS1 | SCN1B | SCN2A | SCN2B | SCN3A | SCN3B | SCN4A | SCN4B | SCN5A | SCN7A | SCN8A | SCN9A | SCNM1 | SCNN1A | SCNN1B | SCNN1D | SCNN1G | SCO1 | SCO2 | SCOC | SCOC-AS1 | SCP2 | SCP2D1 | SCP2D1-AS1 | SCPEP1 | SCRG1 | SCRIB | SCRN1 | SCRN2 | SCRN3 | SCRT1 | SCRT2 | SCT | SCTR | SCUBE1 | SCUBE2 | SCUBE3 | SCXA | SCYL1 | SCYL2 | SDAD1 | SDAD1-AS1 | SDAD1P1 | SDC1 | SDC2 | SDC3 | SDC4 | SDCBP | SDCBP2 | SDCBP2-AS1 | SDCBPP2 | SDCCAG8 | SDE2 | SDF2 | SDF2L1 | SDF4 | SDHA | SDHAF1